Apollo Spectra Hospital - Bangalore

Name :

Apollo Spectra Hospital - Bangalore

Address  :

143, 1st Cross, Near
Nagarjuna Hotel, 5th Block
Koramangala

Town  :

Bengaluru

State  :

Karnataka

Country  :

INDIA

Post Code:

560034

Phone  :

8448440991

Web URL  :

Apollo Spectra Hospital  Bangalore
Specialization
  • Cosmetic Surgery
  • ENT
  • Gastro-enterology
  • General Medicine
  • General Surgeon
  • Gynaecology
  • Nephrology
  • Oncologist
  • Ophthalmology
  • Orthopedics
  • Pain Management
  • Physiology
  • Physiotherapy
  • Plastic Surgery
  • Urology
  • Vascular Surgeon
Facilities

Hospital Area : 20000 Square Feet

Total Number Of Beds : 15

Speciality Type :

Multi Speciality :

  • Surgical General
  • General Indoorcase Medical
  • Gynaecology
  • Orthopedic

Advance Facility

  • Medicine Facility
  • Medical Stores

Description

With a capacity of 15 beds this stateoftheart speciality hospital is committed to bringing together the worldclass medical services and worldrsquos best healthcare management practices The hospital offers expert care in a wide range of surgical specialities including Bariatric Surgery ENT General amp Laparoscopic Surgery Orthopaedics amp Spine Urology Varicose Veins etc Spread over 20000 sqft area the hospital houses 4 ultramodern modular OTs stateoftheart rehabilitation unit inhouse pharmacy inpatientsrsquo family waiting area and so much more

With the singleminded objective of offering simplified quality healthcare over 230 medical professionals including 175 specialist consultants are committed to creating a new standard in healthcare services
25 Bangalore children have asthma

BANGALORE Changing demographics everincreasing air pollution airconditioned houses and offices and different dietary habits have increased the prevalence of asthma one of the most dangerous respiratory disorders in Bangalore A study by the Institute of Medical Education and Research across four Indian cities Delhi Chandigarh Kanpur and Bangalore... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More